Oral care brand BOP has closed a 160 million yuan ($25 million) Series B funding round led by DCM, while genetic testing and diagnostics startup Genskey has raised 100 million yuan ($15 million) in a Series C+ round.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in